1933 Industries Inc.

1933 Industries Inc. is a Vancouver, Canada-based cannabis company engaged in the cultivation and production of cannabis products throughout the United States and Canada. The firm develops, packages, and markets an extensive range of cannabidiol (CBD)-infused items, catering to both the medical and recreational cannabis sectors. Under its Canna Hemp and Canna Hemp X brands, these CBD offerings include tinctures, vape pens, cartridges, topical lotions, pain creams, gummies, and capsules. Beyond CBD, the company also supplies traditional cannabis flowers and concentrates. Consumers can acquire its CBD-infused products via retail dispensaries, other retail establishments, and its dedicated e-commerce platform. The company officially changed its name from Friday Night Inc. to 1933 Industries Inc. in September 2018.

1933 Industries Inc. trades as TGIF.CN on CNQ. The company is classified in Healthcare / Drug Manufacturers - Specialty & Generic and reports in CAD.

The current profile places the business in Drug Manufacturers - Specialty & Generic. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $17.45M of revenue and -$217,042 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

1933 Industries Inc. can be compared against peers such as Aptose Biosciences Inc., Avricore Health Inc., Avant Brands Inc., CanadaBis Capital Inc., Kane Biotech Inc., Lifeist Wellness Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $2.60M, beta of 1.60, and return on equity of +4.7%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

TGIF.CN currently shows total debt of $17.60M and beta of 1.60. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.1933industries.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.